-
Baicalin Methyl Ester: From Structure to Assay
2026-09-19
Baicalin methyl ester is examined here through an evidence-to-assay framework rather than a conventional mechanism summary. Learn how its botanical characterization, P65-linked signaling data, dose boundaries, and barrier endpoints can guide rigorous intestinal inflammation research.
-
JZL184 Workflow for MAGL and 2-AG Studies
2026-09-18
JZL184 is a practical monoacylglycerol lipase inhibitor for connecting 2-AG metabolism with CB1-dependent synaptic, pain, anxiety, and traumatic brain injury phenotypes. This workflow-focused guide explains assay setup, controls, time-course design, and troubleshooting for reproducible endocannabinoid signaling studies.
-
DMH-1: Precision Control of BMP Signaling
2026-09-18
DMH-1 provides a selective ALK2-focused approach for interrogating BMP signaling across human intestinal organoids and non-small cell lung cancer models. This thought-leadership article connects pathway mechanism, assay design, translational qualification, and practical workflow strategy while distinguishing established evidence from forward-looking applications.
-
JZL184 in TBI: A Time-Resolved Assay Strategy
2026-09-17
JZL184 is a selective monoacylglycerol lipase inhibitor for dissecting 2-AG–CB1 signaling after traumatic brain injury. This article translates recent GLT-1/CB1-CREB findings into a practical, time-resolved framework for pharmacology, tissue assays, and behavioral interpretation.
-
IWP-L6: Mapping Wnt-to-Metabolism Causality
2026-09-17
IWP-L6 is a potent Porcupine inhibitor for dissecting how ligand maturation controls Wnt signaling, development, and metabolic osteogenesis. This article provides an assay-centered framework for distinguishing upstream Wnt supply from downstream pathway responses.
-
Anlotinib Hydrochloride for Angiogenesis Assays
2026-09-16
Build a mechanism-led angiogenesis workflow with Anlotinib hydrochloride, linking VEGFR2, PDGFRβ, and FGFR1 inhibition to endothelial migration and tube formation. The guide emphasizes assay design, orthogonal validation, comparison with established TKIs, and troubleshooting that separates anti-angiogenic activity from nonspecific cytotoxicity.
-
Silybin A: From Silymarin Chemistry to Assays
2026-09-15
Silybin A is a defined flavonolignan that enables more interpretable Silymarin research than chemically mixed extracts alone. This guide connects stereochemical chemistry, assay design, solubility control, and translational limits for reproducible liver and inflammation studies.
-
GLT-1, CB1-CREB, and TBI Cognitive Dysfunction
2026-09-15
This 2025 Biomolecules study identifies an astrocyte-centered mechanism linking post-traumatic 2-arachidonoylglycerol accumulation to reduced GLT-1 expression through CB1-CREB signaling. Its pharmacological and behavioral data suggest that restoring glutamate clearance may reduce neuronal apoptosis and cognitive impairment after traumatic brain injury, while also defining important limits for interpreting MAGL-targeted experiments.
-
TH287 MTH1 Inhibitor: Radiosensitization Workflow
2026-09-14
TH287 converts oxidized nucleotide stress into a measurable cancer-cell vulnerability and offers a schedule-sensitive route to radiosensitization. This practical guide connects MTH1 inhibition with viability, apoptosis, DNA-damage, and cell-cycle assays while emphasizing formulation, timing, controls, and interpretation.
-
Z-DEVD-FMK: Caspase-3 Inhibitor Guide
2026-09-14
Z-DEVD-FMK is a cell-permeable, irreversible caspase-3 inhibitor with additional activity against caspases-6, -7, -8, and -10. Its reported calpain inhibition makes it useful for apoptosis assays and experimental traumatic brain injury neuroprotection studies, but it is not a selective caspase-3-only probe or a clinical treatment.
-
Fungal IAA Drives Ferroptosis in Rice Blast Conidia
2026-09-13
A 2026 Molecular Plant Pathology study shows that Magnaporthe oryzae uses fungus-derived indole-3-acetic acid (IAA) to promote iron accumulation, lipid peroxidation, autophagy, and ferroptotic death during conidial development. The work connects phosphatidylethanolamine metabolism with appressorium formation and pathogenicity, identifying lipid regulation as a possible point for future rice blast intervention.
-
Cannabidiol in Orofacial Inflammatory Pain
2026-09-12
This study shows that cannabidiol (CBD) can reduce both inflammatory nociception and pain-associated affective and cognitive deficits through coordinated peripheral, central, endocannabinoid, and serotonergic mechanisms. Its value lies in connecting local inflammatory control with brain circuit responses, while also clarifying the differences between acute orofacial and chronic systemic pain models.
-
GTP Solution for p21 mRNA Workflows
2026-09-12
GTP Solution (100 mM) supports controlled in vitro transcription upstream of p21 mRNA–LNP research, where nucleotide quality can affect RNA yield, integrity, and downstream formulation. Its defined concentration, near-neutral pH, and nuclease-conscious preparation also make it useful for RNA precursor synthesis and GTP-dependent signal transduction assays.
-
S63845 and the Mitochondrial Apoptosis Bottleneck
2026-09-11
S63845 is more than a potent MCL1 inhibitor: it is a precision tool for testing how mitochondrial anti-apoptotic defenses control cancer-cell fate. By connecting S63845 pharmacology with new findings on chlamydial OmpA-mediated blockade of BAX and BAK, this article offers translational researchers a framework for experimental validation, model selection, and biomarker strategy.
-
CSBTA Pharmacokinetics and PXR in MASH Mice
2026-09-11
This 2025 study shows that HFHCD-induced MASH substantially changes the exposure, hepatic distribution, and intracellular accumulation of three Corydalis saxicola Bunting total alkaloids. By combining UHPLC-MS/MS pharmacokinetics with transporter, microsomal metabolism, and PXR-related analyses, it links disease-dependent pharmacokinetic variability to altered Cyp450, Oatp1b2, and P-glycoprotein activity.